ASMC'11 St. Petersburg

4th International Symposium on Advances in Synthetic and Medicinal Chemistry

 St. Petersburg, Russia    August 21-25, 2011

Programme


Tour 1: Pavlovsk and Pushkin
09:00-16:00

Tour 2: Petergof
10:00-17:00

Tour 3: Hermitage
14:00-18:00

14:00

Registration

Tour 4: Boat Trips (Canals)
15:00-18:00

19:30

Welcome Reception

Session Chair

Dr Anthony WOOD
PFIZER, Stevenage, Herts, SG1 2NY, United Kingdom
08:30

Opening

09:00

Maitotoxin. An Inspiration for Synthesis

Prof. K.C. NICOLAOU
THE SCRIPPS RESEARCH INSTITUTE & UNIVERSITY OF CALIFORNIA, Houston, United States
09:50

Tofacitinib (CP-690,550): Discovery of a Potent and Selective JAK Inhibitor

Dr Mark FLANAGAN
PFIZER, Connecticut, United States
10:30

Coffee Break and Exhibition

11:00

A few of my Favorite Rings: Catalysis Inspired by Lactones and Lactams

Prof. Vy M. DONG
UNIVERSITY OF TORONTO, Toronto, Canada
11:50

Small Molecules Inhibitors of the WNT Signalling Pathway with Potential Applications in Oncology

Dr Alessandro PADOVA
SIENA BIOTECH, Siena, Italy
12:30

Lunch and Exhibition

Session Chair

Dr Nikolai KUZNETSOV
INEOS RAS, Moscow, Russia
14:00

Drug Discovery by Programmed Self-Assembly

Prof. Nicolas WINSSINGER
UNIVERSITY OF STRASBOURG, Geneva, Switzerland
14:50

The Many Uses of Noncovalent Mass Spectrometry in Early-stage Drug Discovery

Dr Jean-Paul RENAUD
NOVALIX, Ostwald, France
15:30

Small Molecule Inhibitors of the Neuropilin-1 VEGF-A Interaction

Dr Philip FALLON
DOMAINEX, Saffron Walden, United Kingdom
15:45

Lead identification of a new class of P2Y12 inhibitors "From a low active and insoluble HTS hit to soluble and active lead compounds"

Mr Fredrik ZETTERBERG
ASTRAZENECA, Gothenburg, Sweden
16:00

Coffee Break, Exhibition and Posters

16:30

GPR119: Knowledge Based Lead Identification

Dr Sherrie L. PIETRANICO-COLE
ROCHE, NUTLEY NJ, United States
17:10

Regioselective Reactions on a Chiral Substrate Controlled by the Configuration of a Chiral Catalyst

Prof. Henri KAGAN
UNIVERSITY PARIS-SUD 11, ORSAY Cedex, France
18:00

Closing of the Day

18:30

City Tour for Participants

Session Chair

Dr Christophe GENICOT
UCB SA, Brussels, Belgium
08:30

Synthesis of Marine Polyketides as Promising Anticancer Agents

Prof. Ian PATERSON
CAMBRIDGE UNIVERSITY, Cambridge, United Kingdom
09:20

Chemical Probes for Epigenetics

Dr Mark BUNNAGE
PFIZER, Boston, United States
10:00

The Chemical Biology Consortium- and Experimental Therapeutics Program

Dr Sanjay MALHOTRA
NATIONAL CANCER INSTITUTE, Frederick, United States
10:15

Coffee Break, Exhibition and Posters

10:45

Design Strategy for Preparation of Drug-like Polyheterocycles with Privileged Substructures for Discovery of Specific Small Molecule Modulators

Prof. Seung Bum PARK
SEOUL NATIONAL UNIVERSITY, Seoul, Korea, South
11:35

Bromodomains a New Class of Epigenetic Targets Ripe for Small Molecule Drug Discovery

Dr Jason WITHERINGTON
GLAXOSMITHKLINE R&D, Stevenage, United Kingdom
12:15

Identification of Leads from the Tres Cantos Antimalarial Set: Cyclopropyl Carboxamides Show Good Oral Bioavailability and Efficacy In Malarial Animal Models

Mrs Maria Lourdes RUEDA-BENEDE
GLAXOSMITHKLINE, Tres Cantos, Spain
12:30

Lunch and Exhibition

13:15

Poster Session 1

Session Chair

Prof. Gerhard ECKER
UNIVERSITY OF VIENNA, Vienna, Austria
14:15

Minor Enantiomer Recycling – A Strategy for Improving Enantioselectivity

Prof. Christina MOBERG
KTH SCHOOL OF CHEMICAL SCIENCE AND ENGINEERING, Stockholm, Sweden
15:05

Antibody Directed Cytotoxics

Prof. John FLYGARE
GENENTECH, California, United States
15:45

Exploring the Rigid Mono- and Diamine Chemical Space

Dr Dmytro VOLOCHNYUK
ENAMINE LTD., Kiev, Ukraine
16:00

Highly Efficient Catalytic System for C-H Activation: A Novel and Practical Synthesis of Angiotensin II Receptor Blockers

Dr Masahiko SEKI
MITSUBISHI TANABE PHARMA CORPORATION, Fukuoka, Japan
16:15

Coffee Break, Exhibition and Posters

16:45

Bicyclic Peptides with Tailored Binding Specificities for Therapeutic Application

Prof. Christian HEINIS
ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL), Lausanne, Switzerland
17:05

Adventures in Medicinal Chemistry and Knowledge Capture

Dr Alexander MAYWEG
F. HOFFMANN-LA ROCHE LTD, BASEL, Switzerland
17:25

Target Synthesis Directed Methodology Development

Prof. Dawei MA
SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, Shanghai, China
18:15

Closing of the Day

Session Chair

Dr Edmond DIFFERDING
DIFFERDING CONSULTING, Louvain-la-Neuve, Belgium
08:30

From Homer to Hedgehog: Chemistry, Biological Investigations and Medical Perspectives of Cyclopamine

Prof. Athanassios GIANNIS
UNIVERSITY OF LEIPZIG, Leipzig, Germany
09:20

Biochemical Efficiency, a Metrics for an Optimal Molecular Mechanism of Action

Dr David SWINNEY
IRND3, Mountain View, United States
10:00

Identification of Bisaryloxy Azetidine Urea Derivatives as Fatty Acid Amide Hydrolase Inhibitors

Dr Hans MEISSNER
VERNALIS, Winnersh, United Kingdom
10:15

Coffee Break, Exhibition and Posters

10:45

Lessons in Chemoselectivity: Total Synthesis of Polyphenolic Natural Products

Prof. Scott SNYDER
COLUMBIA UNIVERSITY, New York, United States
11:35

The Resurgence of Covalent Drugs

Dr Juswinder SINGH
AVILA THERAPEUTICS, United States
12:15

Halogen Bonding in Protein–ligand Interactions

Mr Leo HARDEGGER
ETH ZURICH, Zürich, Switzerland
12:30

Lunch and Exhibition

13:15

Poster Session 2

Free Afternoon

Tour 5: Hermitage
14:30-18:30

Tour 6: Canals
15:00-18:00

Session Chair

Prof. Nicolas WINSSINGER
UNIVERSITY OF STRASBOURG, Geneva, Switzerland
08:30

Validation of N-Myristoyltransferase as a Drug Target

Prof. Paul WYATT
UNIVERSITY OF DUNDEE, Dundee, United Kingdom
09:20

Novel Metabotropic Glutamate Receptor 4 (mGluR4) Allosteric Potentiators for the Treatment of Parkinsons’s Disease

Dr Sylvain CELANIRE
ADDEX PHARMACEUTICALS, Geneva, Switzerland
10:00

The Chemistry of Targeting Protein-Protein Interactions: Thinking Outdside of the Box

Dr Giovanna ZINZALLA
CANCER RESEARCH UK - THE SCHOOL OF PHARMACY, UNIVERSITY OF LONDON, London, United Kingdom
10:15

Coffee Break, Exhibition and Posters

10:45

Asymmetric Synthesis of Bioactive Molecules

Prof. Mikiko SODEOKA
RIKEN, Hirosawa, Japan
11:35

A Step Closer to Hepatitis C Remedy: TMC435, an HCV Protease Inhibitor in Advanced Clinical Trial

Dr Pierre RABOISSON
JANSSEN PHARMACEUTICAL COMPANIES, Mechelen, Belgium
12:15

The Grandisine Alkaloids as Selective δ-Opioid Receptor Agonists; When is a Natural Product not a Natural Product?

Prof. Richard TAYLOR
UNIVERSITY OF YORK, York, United Kingdom
12:45

Lunch and Exhibition

Session Chair

Prof. K.C. NICOLAOU
THE SCRIPPS RESEARCH INSTITUTE & UNIVERSITY OF CALIFORNIA, Houston, United States
14:00

Discovery and Development of Novel Antimalarials

Dr Rodney KIP GUY
ST. JUDE CHILDREN'S RESEARCH HOSPITAL, Memphis, United States
14:50

Accelerated C-H Activation Reactions: Enantioselectivity and Positional Selectivity

Prof Jin-Quan YU
THE SCRIPPS RESEARCH INSTITUTE, La Jolla, United States
15:40

Coffee Break and Exhibition

16:10

Metal-Catalyzed C–H Bond Functionalizations for Sustainable Synthesis

Prof. Lutz ACKERMANN
GEORG-AUGUST UNIVERSITY GOETTINGEN, Goettingen, Germany
17:00

Magical Power of d-Block Transition Metals—Pd-Catalyzed Cross-Coupling and Zr-Catalyzed Asymmetric carboalumination of Alkenes (ZACA)

Prof. Ei-ichi NEGISHI
PURDUE UNIVERSITY, West Lafayette, United States
17:50

Closing Remarks

19:00

Symposium Banquet

Tour 7: Pavlovsk-Pushki
09:00-18:00

Tour 8: Petergof
10:00-17:00